HIGHLIGHTS
- who: Valentine Deprez and colleagues from the Department of Rheumatology, Amiens University Hospital, Amiens, France have published the article: Therapeutic Maintenance of Baricitinib and Tofacitinib in Real Life, in the Journal: (JOURNAL) of 20/05/2020
- what: The aim of this study was to evaluate the effectiveness tolerance profile and maintenance of these treatments (tofacitinib and baricitinib) in real life. The authors aimed to study the JAKi maintenance rate at 12 months and their clinical and biological safety profiles. This study showed a slight decrease in hemoglobin (mean of -0.5 g/dL at six . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.